IF's resources are committed through 2019. We anticipate accepting grant applications in 2020.
Immunotherapy Foundation (IF) is committed to providing grants for immunotherapy research in the following areas: checkpoint blockade, adoptive cell-based therapies, and therapeutic vaccines. IF will focus on advancing projects that demonstrate a high likelihood of being in a clinical trial setting within two years of grant funding.